evodiamine has been researched along with Innate Inflammatory Response in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, J; Fu, S; Gao, X; He, D; Hu, G; Huang, B; Liu, D; Meng, T; Su, Y; Zhang, Y; Zhou, A | 1 |
| Cui, Y; Wang, J; Wang, Q; Wu, X | 1 |
| Han, B; Huang, W; Li, X; Peng, C; Xie, X; Ye, C; Zhang, N; Zhao, Q; Zhu, HP | 1 |
| Kim, JB; Kim, SH; Lee, P; Yang, JY | 1 |
| Fan, X; Liang, HP; Luo, L; Ma, W; Sun, Y; Tang, WQ; Yan, J; Yang, X; Yu, J; Zhu, JY | 1 |
| Eraslan, E; Polat, E; Tanyeli, A; Yetim, Z | 1 |
| Han, S; Jung, Y; Kang, C; Kim, E; Kim, W; Kwon, T; Lee, S; Yang, HJ; Youn, B; Youn, H | 1 |
| Dhulap, S; Gavaraskar, K; Hirwani, RR | 1 |
| Gao, Y; Guo, L; Li, G; Liang, S; Liu, S; Lv, Q; Wang, S; Xie, J; Xu, H; Xue, Y; Ying, M; Zhang, X; Zou, L | 1 |
| Aggarwal, BB; Kobayashi, Y; Takada, Y | 1 |
1 review(s) available for evodiamine and Innate Inflammatory Response
| Article | Year |
|---|---|
Therapeutic and cosmetic applications of Evodiamine and its derivatives--A patent review.
Topics: Alkaloids; Animals; Autoimmune Diseases; Cell Line, Tumor; Central Nervous System Diseases; Cosmetics; Evodia; Fruit; Humans; Inflammation; Metabolic Diseases; Molecular Structure; Neoplasms; Patents as Topic; Quinazolines | 2015 |
9 other study(ies) available for evodiamine and Innate Inflammatory Response
| Article | Year |
|---|---|
Evodiamine Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in BV-2 Cells via Regulating AKT/Nrf2-HO-1/NF-κB Signaling Axis.
Topics: Animals; Cell Line; Cell Nucleus; Cell Survival; Heme Oxygenase-1; Inflammation; Inflammation Mediators; Lipopolysaccharides; Mice; Models, Biological; Neuroglia; Neurons; NF-E2-Related Factor 2; NF-kappa B; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Tyrosine 3-Monooxygenase; Up-Regulation | 2021 |
Evodiamine protects against airway remodelling and inflammation in asthmatic rats by modulating the HMGB1/NF-κB/TLR-4 signalling pathway.
Topics: Airway Remodeling; Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Evodia; HMGB1 Protein; Inflammation; NF-kappa B; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4 | 2021 |
Evodiamine alleviates lipopolysaccharide-induced pulmonary inflammation and fibrosis by activating apelin pathway.
Topics: Animals; Apelin; Apoptosis; Cytokines; Evodia; Fibrosis; Humans; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Plant Extracts; Pneumonia; Quinazolines; RAW 264.7 Cells | 2021 |
Evodiamine Inhibits
Topics: Antigens, Bacterial; Cell Nucleus; Cytokines; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Interleukin-8; MAP Kinase Signaling System; Microbial Sensitivity Tests; NF-kappa B; NF-kappa B p50 Subunit; Quinazolines; Signal Transduction; Subcellular Fractions; Type IV Secretion Systems | 2021 |
Evodiamine Inhibits Zymosan-Induced Inflammation In Vitro and In Vivo: Inactivation of NF-κB by Inhibiting IκBα Phosphorylation.
Topics: Cytokines; Humans; Inflammation; Intestinal Mucosa; Lung; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Quinazolines; Zymosan | 2017 |
Evodiamine alleviates kidney ischemia reperfusion injury in rats: A biochemical and histopathological study.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Caspase 3; Gene Expression Regulation; Inflammation; Interleukin-10; Interleukin-1beta; Interleukin-6; Kidney; Male; NF-kappa B; Oxidative Stress; Quinazolines; Rats; Rats, Wistar; Reactive Oxygen Species; Renal Artery; Reperfusion Injury; Surgical Instruments; Treatment Outcome; Tumor Necrosis Factor-alpha | 2019 |
Inhibition of hedgehog signalling attenuates UVB-induced skin photoageing.
Topics: Aging; Anilides; Animals; Cell Line; Cyclooxygenase 2; Cytokines; Drug Evaluation, Preclinical; Flavonoids; Gene Expression Regulation; Hedgehog Proteins; Humans; Inflammation; MAP Kinase Signaling System; Mice; Pyridines; Quinazolines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Skin Aging; Tissue Inhibitor of Metalloproteinase-1; Ultraviolet Rays | 2015 |
Beneficial effects of evodiamine on P2X(4)-mediated inflammatory injury of human umbilical vein endothelial cells due to high glucose.
Topics: Drugs, Chinese Herbal; Endothelium, Vascular; Evodia; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; NF-kappa B; Nitric Oxide; Quinazolines; Reactive Oxygen Species; Receptors, Purinergic P2X4; Receptors, Tumor Necrosis Factor; Umbilical Veins; Up-Regulation | 2015 |
Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion.
Topics: Active Transport, Cell Nucleus; Alkaloids; Annexin A5; Apoptosis; Carcinogens; Cell Line, Tumor; Cell Proliferation; Collagen; Cytokines; Dose-Response Relationship, Drug; Down-Regulation; Drug Combinations; Enzyme Activation; Evodia; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; I-kappa B Kinase; Immunohistochemistry; Immunoprecipitation; In Situ Nick-End Labeling; Indole Alkaloids; Inflammation; Laminin; MAP Kinase Signaling System; Microscopy, Fluorescence; Models, Chemical; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Extracts; Protein Serine-Threonine Kinases; Proteoglycans; Quinazolines; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation | 2005 |